Urinary Fetuin-A Fragments Predict Progressive eGFR Decline in Two Independent Type 2 Diabetes Cohorts of Different Ethnicities
Conclusion uPTM-FetA was independently associated with kidney function decline in patients with type 2 diabetes validated in a 2-cohort study. The significant additive predictive power of this biomarker from conventional risk factors suggests its clinical use for renal function progression in patients with type 2 diabetes.PMID:37812932 | DOI:10.1159/000534514
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Gwo-Tsann Chuang Daan Kremer Chi-Hsuan Huang Firas F Alkaff Chih-Hung Lin Tzu-Ling Tseng Gozewijn D Laverman Stephan J L Bakker Lee-Ming Chuang Source Type: research
More News: Diabetes | Diabetes Type 2 | Endocrinology | Netherlands Health | Study | Taiwan Health | Urology & Nephrology